Pfizer requests authorization for its antiviral COVID pill as cases rise across U.S.


Pfizer is requesting FDA authorization of its antiviral COVID-19 pill. The company’s study found it is nearly 90% effective in cutting hospitalizations and deaths from the virus. Meanwhile, at least 20 states are experiencing upticks in infections. Infectious disease physician at the University of Michigan Dr. Payal Patel joins CBSN’s Elaine Quijano to discuss the latest pandemic news.

Read More

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More